XML 15 R5.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Cash flows from operating activities:    
Net income/(loss) $ (989,000) $ 247,000
Adjustments to reconcile net income/(loss) to net cash (used in) provided by operating activities:    
Depreciation and amortization 120,000 151,000
Equity compensation expense 127,000 11,000
Change in assets and liabilities:    
Accounts receivable 545,000 (1,341,000)
Inventories 347,000 686,000
Prepaid expenses and other assets (21,000) (47,000)
Trade payables (70,000) (331,000)
Accrued liabilities 49,000 (737,000)
Net cash provided by (used in) operating activities 108,000 (1,361,000)
Cash flows from investing activities:    
Purchases of property, plant and equipment (274,000) (94,000)
Net cash used in investing activities (274,000) (94,000)
Cash flows from financing activities:    
Receipt for preferred stock issuance 500,000
Repayment of note payable, related party (1,000,000)
Net advances (repayments) of term loan (30,000) (90,000)
Net advances (repayments) on revolving line of credit (203,000) 1,499,000
Net cash (used in) provided by financing activities (733,000) 1,409,000
Net (decrease) / increase in cash and cash equivalents (899,000) (46,000)
Cash and cash equivalents at beginning of period 921,000 146,000
Cash and cash equivalents at end of period 22,000 100,000
Supplemental disclosure of cash flow information and noncash investing and financing activities:    
Cash payments for interest 454,000 259,000
Accretion of dividends on preferred stock 70,000 11,000
Common stock issued in exchange for assets acquired 6,250,000
Allocation of proceeds from preferred stock financing to the issuance of warrants for preferred stock 814,000
Reclassification of advances upon issuances of preferred stock 1,500,000
Conversion of notes and deposits into common stock 885,000
Conversion of Series B preferred stock into common stock $ 1,500,000